CCND3 and acute myeloid leukemia: Within the FLT3‐ITD‐positive group, we identified mutations in both BCOR (F: 0/62, M: 4/61, P = 0.057) and CCND3 (F: 0/62, M: 4/61, P = 0.057) only in male FLT3‐ITD AML (Table S4B).